title: Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
authors.affiliation: Department of Medicine, University of Nijmegen, The Netherlands.
authors.forename: A J
authors.initials: AJ
authors.lastname: Hoitsma
authors.forename: R G
authors.initials: RG
authors.lastname: Tiggeler
authors.forename: J F
authors.initials: JF
authors.lastname: Wetzels
authors.forename: J H
authors.initials: JH
authors.lastname: Berden
authors.forename: R A
authors.initials: RA
authors.lastname: Koene
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000097:blood / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine